Why it’s a good year for diagnostics startups
Venture capitalists have typically shied away from investing in diagnostics. That mentality has changed, and a GE Ventures executive explains why.
Illumina embarks on its own next-gen journey
With a new tumor profiling panel, Illumina continues its transformation from a research tools provider to a genetic healthcare company.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.